Logo

American Heart Association

  32
  0


Final ID: 4368252

A Novel Role for ANPEP in Osteogenic Signaling and Aortic Valve Calcification

Abstract Body (Do not enter title and authors here): Introduction
Calcific aortic valve disease (CAVD) is one of the most common valvular diseases, predominantly characterized by progressive calcification of the aortic valve. Although minimally invasive treatments such as transcatheter aortic valve replacement (TAVR) have advanced rapidly, there remains a lack of effective strategies to delay or reverse the progression of CAVD. This study investigates underlying molecular mechanisms of CAVD to explore new therapeutic avenues.
Methods
Three publicly available human bulk RNA-seq datasets related to CAVD were analyzed. Genes upregulated across all three datasets were identified and intersected to find shared targets. Aortic valve tissues from healthy individuals and CAVD patients were collected, and Western blotting was used to validate expression levels of candidate genes. In vitro, small interfering RNA (siRNA) was used to knock down the target gene in valvular interstitial cells (VICs), evaluating its effect on calcification markers. In vivo, we generated ANPEP knockout mice (ANPEP-/-/ApoE-/-) via breeding and subjected them to a high-fat diet to induce valve calcification. Alizarin Red S staining was performed to assess the extent of calcification.
Results
Only two genes—ANPEP and CTHRC1—were commonly upregulated across all datasets. CTHRC1 has been previously studied in CAVD, while ANPEP, a zinc-dependent type II metalloprotease primarily expressed on the cell membrane, has not. Western blot analysis confirmed significantly increased ANPEP expression in calcified human valve tissue. siRNA-mediated knockdown of ANPEP in VICs led to marked reductions in calcification markers such as BMP2 and RUNX2, suggesting its role in calcification. In vivo, ANPEP-deficient mice showed significantly less aortic valve calcification, aligning with in vitro findings.
Conclusion
These results indicate that ANPEP plays a critical role in the progression of CAVD and may serve as a promising target for the diagnosis and treatment of aortic stenosis due to valve calcification.
  • Fan, Jianing  ( Zhongshan hospital Fudan University , Shanghai , China )
  • Chen, Qixin  ( Zhongshan Hospital , Shanghai , China )
  • Miao, Jiaxin  ( fudan university , Shanghai , China )
  • Li, Zhenzhen  ( Zhongshan hospital Fudan University , Shanghai , China )
  • Zhou, Daxin  ( Zhongshan hospital Fudan University , Shanghai , China )
  • Ge, Junbo  ( ZHONGSHAN HOSPITAL FUDAN UNIVERSITY , Shanghai , China )
  • Author Disclosures:
    Jianing Fan: DO NOT have relevant financial relationships | Qixin Chen: DO NOT have relevant financial relationships | Jiaxin Miao: DO NOT have relevant financial relationships | Zhenzhen Li: No Answer | Daxin Zhou: No Answer | Junbo Ge: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Valve Science Spotlight: Top Research in Valve Disease

Friday, 11/07/2025 , 02:15PM - 03:30PM

Abstract Oral Session

More abstracts on this topic:
Comparative Effectiveness of Cardiac Rehabilitation After Surgical Aortic Valve Replacement – A Target Trial Emulation

Rr Decker Sergio, Rosa Regis, Yeh Robert, Sperling Laurence, Fonarow Gregg, Keteyian Steven, Beatty Alexis, Dahabreh Issa, Kazi Dhruv, Essa Mohammed, Song Yang, Liang Lichen, Inoue Kosuke, Mcconeghy Kevin, Wu Wen-chih, Varghese Merilyn, Thompson Mike

Aortic Stenosis is Promoted by Ferroptosis via 5-Lipoxygenase

Qin Zihan, Haftbaradaran Esfahani Payam, Pawelzik Sven-christian, Bosman Matthias, Bergstrom Goran, Guns Pieter-jan, Franco-cereceda Anders, Back Magnus

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available